Literature DB >> 19958934

Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families.

Insoo Suh1, Sebastiano Filetti, Menno R Vriens, Marlon A Guerrero, Salvatore Tumino, Mariwil Wong, Wen T Shen, Electron Kebebew, Quan-Yang Duh, Orlo H Clark.   

Abstract

BACKGROUND: Familial nonmedullary thyroid cancer (FNMTC) is associated with earlier onset and more aggressive behavior than its sporadic counterpart. Although candidate chromosomal loci have been proposed for isolated families with variants of FNMTC, the etiology of most cases is unknown. We aimed to identify loci linked to FNMTC susceptibility using single-nucleotide polymorphism (SNP) array-based linkage analysis in a broad sampling of affected families.
METHODS: We enrolled and pedigreed 38 FNMTC families. Genomic DNA was extracted from the peripheral blood of 110 relatives, and hybridized to Affymetrix SNP arrays. We performed genotyping and linkage analysis, calculating exponential logarithm-of-the-odds (LOD) scores to identify chromosomal loci with a significant likelihood of linkage.
RESULTS: Forty-nine affected and 61 unaffected members of FNMTC families were genotyped. In pooled linkage analysis of all families, 2 distinct loci with significant linkage were detected at 6q22 and 1q21 (LOD=3.3 and 3.04, respectively).
CONCLUSION: We have identified 2 loci on chromosomes 1 and 6 that demonstrate linkage in a broad sampling of FNMTC families. Our findings suggest the presence of germline mutations in heretofore-undiscovered genes at these loci, which may potentially lead to accurate genetic tests. Future studies will consist of technical validation and subset analyses of higher-risk pedigrees.

Entities:  

Mesh:

Year:  2009        PMID: 19958934     DOI: 10.1016/j.surg.2009.09.012

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  21 in total

Review 1.  Controversies in familial thyroid cancer 2014.

Authors:  Orlo H Clark
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

2.  Common genetic variant on 14q13.3 contributes to thyroid cancer susceptibility: evidence based on 12 studies.

Authors:  JiaoJiao Zheng; Chen Li; Cong Wang; Zhilong Ai
Journal:  Mol Genet Genomics       Date:  2015-01-01       Impact factor: 3.291

3.  Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.

Authors:  Sandya Liyanarachchi; Anna Wojcicka; Wei Li; Malgorzata Czetwertynska; Elzbieta Stachlewska; Rebecca Nagy; Kevin Hoag; Bernard Wen; Rafal Ploski; Matthew D Ringel; Izabella Kozłowicz-Gudzinska; Wojciech Gierlikowski; Krystian Jazdzewski; Huiling He; Albert de la Chapelle
Journal:  Thyroid       Date:  2013-08-29       Impact factor: 6.568

4.  A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.

Authors:  Huiling He; Wei Li; Daniel F Comiskey; Sandya Liyanarachchi; Taina T Nieminen; Yanqiang Wang; Katherine E DeLap; Pamela Brock; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-02       Impact factor: 6.568

5.  Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.

Authors:  Aida Orois; Celia Badenas; Jordi L Reverter; Verónica López; Miriam Potrony; Mireia Mora; Irene Halperin; Josep Oriola
Journal:  Horm Cancer       Date:  2020-03-14       Impact factor: 3.869

6.  Germline Mutations in Familial Papillary Thyroid Cancer.

Authors:  Marta Sarquis; Debora C Moraes; Luciana Bastos-Rodrigues; Pedro G Azevedo; Adauto V Ramos; Fabiana Versiani Reis; Paula V Dande; Isabela Paim; Eitan Friedman; Luiz De Marco
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

7.  A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.

Authors:  Carolina Pires; Inês Jorge Marques; Daniela Dias; Ana Saramago; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2021-03-08       Impact factor: 3.633

Review 8.  Genetic predisposition for nonmedullary thyroid cancer.

Authors:  Rebecca Nagy; Matthew D Ringel
Journal:  Horm Cancer       Date:  2014-10-22       Impact factor: 3.869

9.  'Chromosomal Rainbows' Detect Oncogenic Rearrangements of Signaling Molecules in Thyroid Tumors.

Authors:  Benjamin O'Brien; Gregg H Jossart; Yuko Ito; Karin M Greulich-Bode; Jingly F Weier; Santiago Munne; Orlo H Clark; Heinz-Ulrich G Weier
Journal:  Open Cell Signal J       Date:  2010

10.  SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.

Authors:  Huiling He; Agnieszka Bronisz; Sandya Liyanarachchi; Rebecca Nagy; Wei Li; Yungui Huang; Keiko Akagi; Motoyasu Saji; Dorota Kula; Anna Wojcicka; Nikhil Sebastian; Bernard Wen; Zbigniew Puch; Michal Kalemba; Elzbieta Stachlewska; Malgorzata Czetwertynska; Joanna Dlugosinska; Kinga Dymecka; Rafal Ploski; Marek Krawczyk; Patrick J Morrison; Matthew D Ringel; Richard T Kloos; Krystian Jazdzewski; David E Symer; Veronica J Vieland; Michael Ostrowski; Barbara Jarząb; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.